The company manufactures, refines, and sells a variety of edible oils including groundnut, coconut, mustard, and sesame oils under established brands like Guinea and Cocoraj to retail and bulk consumers.
While the company possesses legacy brands, the financial performance contradicts any claim of a durable moat; net margins are deeply negative on average and ROCE is below the cost of capital, suggesting the brands lack significant pricing power or cost advantages.
Capital has been primarily directed toward maintaining operations and settling legacy liabilities under an NCLT resolution plan; the company has not paid dividends and recently sought to increase borrowing limits and executive pay despite inconsistent profitability.
The company's collapse was driven by its inability to outrun a crushing debt load of 13 times equity, which eventually triggered a second insolvency event. While management sought to triple their own pay, the structural unprofitability evidenced by -45% net margins never corrected, and the legacy brands proved to be 'commodity-plus' at best, lacking any real pricing power. The preferential allotments to non-promoters diluted existing shareholders into oblivion while the cash flow remained non-existent, leaving the business unable to settle its untraceable legacy liabilities or fund basic operations.
RichFakir rates Raj Oil Mills Ltd's business quality as poor — 13/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Raj Oil Mills Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Raj Oil Mills Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Raj Oil Mills Ltd's fair value is about ₹19 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →